↓ Skip to main content

Dove Medical Press

Article Metrics

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2018
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
88 Mendeley
Title
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma
Published in
Therapeutics and Clinical Risk Management, May 2018
DOI 10.2147/tcrm.s145039
Pubmed ID
Authors

Michael D Jain, Christina A Bachmeier, Vania H Phuoc, Julio C Chavez

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 88 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 16%
Student > Ph. D. Student 12 14%
Researcher 9 10%
Student > Bachelor 9 10%
Other 6 7%
Other 11 13%
Unknown 27 31%
Readers by discipline Count As %
Medicine and Dentistry 17 19%
Biochemistry, Genetics and Molecular Biology 17 19%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Agricultural and Biological Sciences 4 5%
Engineering 4 5%
Other 8 9%
Unknown 28 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2019.
All research outputs
#12,869,658
of 14,570,779 outputs
Outputs from Therapeutics and Clinical Risk Management
#936
of 1,016 outputs
Outputs of similar age
#227,421
of 267,159 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#3
of 3 outputs
Altmetric has tracked 14,570,779 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,016 research outputs from this source. They receive a mean Attention Score of 4.7. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,159 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.